Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 1,165 people who get email alerts on ACT.

Get email alerts on ACT »

Market Currents

Watson Pharmaceuticals (WPI) receives FDA approval for a generic version of Vancocin and plans...

Tuesday, April 10, 2012, 8:17 AM ET
Watson Pharmaceuticals (WPI) receives FDA approval for a generic version of Vancocin and plans to begin shipping the products immediately.

This Market Current was sent to 1,165 people who get email alerts on ACT.

Get email alerts on ACT »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles

Nanospheres High Margin Pathogen Identification System Shows Promise
9:45 AM • Healthcare Specialist
Dendreon Analysts Getting Very Skeptical
8:49 AM • Bill Maurer
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
8:34 AM • The Swiss Trader
The 'New' Celsion Could Be Worth $4 A Share
8:28 AM • Quoth the Raven
Neuralstem Phase I Results Encourage Market, Stimulate Buying
7:33 AM • Brian L. Wilson
Prolor Biotech Buyout: Is The Opko Bear Case Now Dead?
6:10 AM • Daniel Lauchheimer
Hodgkin Lymphoma: The Top Secret Strategy Of Seattle Genetics Revealed
6:02 AM • Michael Webb
Pricing A Highly Probable Takeover Of MannKind
5:28 AM • George Rho
Cumberland Pharma On The Right Track... But Moving Slowly
4:38 AM • Vince Martin
Arena Pharmaceuticals - Out To Launch Or Out To Lunch?
3:19 AM • Spencer Osborne
Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide
1:41 PM • PropThink
Bull Of The Day: Heartware
12:48 PM • Zacks Investment Research
Thermo Fisher A Decent Long-Term Opportunity
11:35 AM • Fundamental Analyst
A Game-Changing Cancer Screen For Exact Sciences
10:57 AM • Biotech Vet
Long-Term Biotech: 3 Names To Discover Now
9:42 AM • G. Putnam Kling

More Latest Articles »